Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

AVNS
Avanos Medical, Inc.
stock NYSE

At Close
Jul 24, 2026 3:59:59 PM EDT
24.99USD+0.040%(+0.01)2,075,760
0.00Bid   0.00Ask   0.00Spread
Pre-market
Jul 24, 2026 8:44:30 AM EDT
24.98USD0.000%(0.00)384
After-hours
Jul 24, 2026 4:14:30 PM EDT
25.01USD+0.080%(+0.02)1,618,933
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 10, 2022
09:08AM EST  Avanos Medical, Inc. to Present at the 40th Annual J.P. Morgan Healthcare   PR Newswire
Jan 7, 2022
01:04PM EST  Morgan Stanley Maintains Underweight on Avanos Medical, Lowers Price Target to $36   Benzinga
Dec 15, 2021
04:19PM EST  Avanos Medical, Inc. Announces $30M Buyback   Benzinga
04:15PM EST  Avanos Medical, Inc. Announces Share Repurchase Authorization   PR Newswire
Dec 14, 2021
08:32AM EST  Annovis Bio Announces Publication Of ANVS401 Mechanism Of Action In Peer-Reviewed Pharmaceutics   Benzinga
Dec 13, 2021
04:11PM EST  Avanos Medical Announces Agreement To Acquire OrthogenRx   RTTNews
04:06PM EST  Avanos Medical To Acquire OrthogenRx For ~$130M Plus Additional $30M In Cash   Benzinga
04:05PM EST  Avanos Medical, Inc. Announces Agreement To Acquire OrthogenRx, Inc.   PR Newswire
Dec 2, 2021
10:04AM EST  Avanos Medical, Inc. Launches PainBlock Pro App   Benzinga
Nov 2, 2021
10:54AM EDT  The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US   Benzinga
10:50AM EDT  Avanos Medical Q3 EPS $0.25 Misses $0.30 Estimate, Sales $184.10M Miss $185.34M Estimate   Benzinga
10:41AM EDT  Earnings Scheduled For November 2, 2021   Benzinga
07:04AM EDT  Avanos Medical Q3 Net Loss $35 Mln Vs. Net Income $19 Mln Last Year   RTTNews
07:01AM EDT  Avanos Medical, Inc. Announces Third Quarter 2021 Results   PR Newswire
Oct 31, 2021
02:24PM EDT  The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline   Benzinga
Oct 26, 2021
07:01AM EDT  Avanos Medical, Inc. To Webcast Conference Call Discussing Third Quarter 2021   PR Newswire
Sep 15, 2021
07:38AM EDT  The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs   Benzinga
Sep 14, 2021
07:50AM EDT  The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout   Benzinga
Aug 19, 2021
03:23PM EDT  Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2021   Benzinga
Aug 4, 2021
08:36AM EDT  Morgan Stanley Maintains Underweight on Avanos Medical, Lowers Price Target to $41   Benzinga
08:02AM EDT  Stephens & Co. Downgrades Avanos Medical to Equal-Weight, Lowers Price Target to $45   Benzinga
04:33AM EDT  Keybanc Maintains Overweight on Avanos Medical, Lowers Price Target to $47   Benzinga
Aug 3, 2021
07:43AM EDT  Avanos Medical: Q2 Earnings Insights   Benzinga
07:22AM EDT  Avanos Narrows FY21 Adj. EPS Guidance From $1.10-$1.25 To $1.10-$1.20 vs $1.21 Est.   Benzinga
07:21AM EDT  Avanos Medical Q2 EPS $0.21 Misses $0.23 Estimate, Sales $186.40M Beat $180.56M Estimate   Benzinga
07:02AM EDT  Avanos Medical, Inc. Announces Second Quarter 2021 Results   PR Newswire
03:52AM EDT  Earnings Scheduled For August 3, 2021   Benzinga
Jul 12, 2021
07:19AM EDT  Avanos Medical Appoints Moji James As SVP & General Counsel   RTTNews
07:15AM EDT  Avanos Medical, Inc. Appoints Moji James as Senior Vice President & General   PR Newswire
Jun 18, 2021
07:00AM EDT  Avanos Medical, Inc. to Present at the 2021 Raymond James Human Health   PR Newswire
May 10, 2021
06:38PM EDT  Charles River Laboratories International Set to Join S&P 500; Others to Join   PR Newswire
May 7, 2021
07:40AM EDT  The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs   Benzinga
07:34AM EDT  Avanos Medical Q1 Loss/shr $0.16 Vs EPS $0.08 Last Year   RTTNews
07:18AM EDT  Avanos Medical Sees FY21 EPS $1.10-$1.25 Vs $1.19 Est   Benzinga
07:14AM EDT  Avanos Medical Q1 EPS $0.23 Beats $0.18 Estimate, Sales $181.00M Beat $175.44M Estimate   Benzinga
07:00AM EDT  Avanos Medical, Inc. Announces First Quarter 2021 Results   PR Newswire
04:12AM EDT  Earnings Scheduled For May 7, 2021   Benzinga
May 6, 2021
10:14AM EDT  Earnings Preview for Avanos Medical   Benzinga
Apr 30, 2021
07:00AM EDT  Avanos Medical, Inc. To Webcast Conference Call Discussing First Quarter 2021   PR Newswire
Mar 16, 2021
07:01AM EDT  Avanos Medical, Inc. to Present at the KeyBanc Life Sciences & MedTech Investor   PR Newswire
Feb 24, 2021
07:00AM EST  Avanos Medical, Inc. to Present at the Virtual Raymond James 42nd Annual   PR Newswire
Feb 19, 2021
07:25AM EST  The Daily Biotech Pulse: Novavax Vaccine Supply Deal, Orphan Drug Designation For Travere, COVID-19 Boost For Quidel, Opko   Benzinga
Feb 18, 2021
08:14AM EST  The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout   Benzinga
07:45AM EST  Avanos Medical Q4 Loss Per Share $0.99; Adj EPS $0.28   RTTNews
07:36AM EST  Recap: Avanos Medical Q4 Earnings   Benzinga
07:05AM EST  Avanos Medical Q4 EPS $0.28 Beats $0.22 Estimate, Sales $185.00M Beat $184.15M Estimate   Benzinga
07:00AM EST  Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2020 Results   PR Newswire
04:28AM EST  Earnings Scheduled For February 18, 2021   Benzinga
Feb 17, 2021
10:12AM EST  Avanos Medical's Earnings Outlook   Benzinga
07:27AM EST  The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal   Benzinga
Feb 11, 2021
07:01AM EST  Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and   PR Newswire
Jan 8, 2021
04:41AM EST  KeyBanc Maintains Overweight on Avanos Medical, Raises Price Target to $55   Benzinga
Jan 6, 2021
07:00AM EST  Avanos Medical, Inc. to Present at the 39th Annual J.P. Morgan Healthcare   PR Newswire
Dec 18, 2020
07:48AM EST  The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Vote, Mesoblast Sinks On Data   Benzinga
07:45AM EST  The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Approved, Mesoblast Sinks On Data   Benzinga
Dec 15, 2020
11:23AM EST  Morgan Stanley Maintains Underweight on Avanos Medical, Raises Price Target to $45   Benzinga
Dec 10, 2020
07:42AM EST  The Daily Biotech Pulse: Key Vaccine Adcom Review For Pfizer-BioNTech, Puma, Immutep, G1 Rally On Breast Cancer Conference Presentations   Benzinga
Dec 8, 2020
08:04AM EST  The Daily Biotech Pulse: ASH Presentations, Axsome's Positive Midstage Readout, Follow-On Offerings   Benzinga
Nov 5, 2020
07:01AM EST  Avanos Medical, Inc. to Present at Two Virtual Investor Conferences in November   PR Newswire
Nov 4, 2020
08:05AM EST  Morgan Stanley Maintains Underweight on Avanos Medical, Raises Price Target to $36   Benzinga
03:57AM EST  KeyBanc Maintains Overweight on Avanos Medical, Raises Price Target to $47   Benzinga
Nov 3, 2020
07:38AM EST  The Daily Biotech Pulse: Aurinia Pulls The Plug On Dry Eye Disease Study, Karyopharm's Positive Readout, Emergency Use Authorization For OraSure   Benzinga
07:24AM EST  Avanos Medical Q3 EPS $0.40 Vs. Loss/shr $0.24 Last Year   RTTNews
07:06AM EST  Avanos Medical Q3 Adj. EPS $0.21 Beats $0.10 Estimate, Sales $185.70M Beat $165.87M Estimate   Benzinga
07:00AM EST  Avanos Medical, Inc. Announces Third Quarter 2020 Results   PR Newswire
04:07AM EST  Earnings Scheduled For November 3, 2020   Benzinga
Nov 1, 2020
09:40AM EST  The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings   Benzinga
Oct 27, 2020
07:00AM EDT  Avanos Medical, Inc. To Webcast Conference Call Discussing Third Quarter 2020   PR Newswire
Sep 15, 2020
07:14AM EDT  Avanos Medical Names Michelle Scharfenberg As SVP & Chief Ethics And Compliance Officer   RTTNews
07:00AM EDT  Avanos Medical, Inc. Appoints Michelle Scharfenberg as Senior Vice President &   PR Newswire
Sep 4, 2020
07:00AM EDT  Avanos Medical, Inc. to Present at Two Virtual Investor Conferences in September   PR Newswire
Sep 3, 2020
07:01AM EDT  Superiority of COOLIEF* over Hyaluronic Acid Injections for the Management of Chronic Knee Pain   PR Newswire
Aug 31, 2020
04:01PM EDT  Avanos Medical, Inc. Appoints Bill Haydon as Senior Vice President & General   PR Newswire
Aug 5, 2020
04:54AM EDT  KeyBanc Maintains Overweight on Avanos Medical, Lowers Price Target to $43   Benzinga
Aug 4, 2020
07:24AM EDT  Avanos Medical Q2 Adj. EPS $0.13 Beats $(0.10) Estimate, Sales $163.70M Beat $147.90M Estimate   Benzinga
07:12AM EDT  Avanos Medical Q2 Net Sales Down 5% To $164 Mln   RTTNews
07:01AM EDT  Avanos Medical, Inc. Announces Second Quarter 2020 Results   PR Newswire
05:19AM EDT  Earnings Scheduled For August 4, 2020   Benzinga
Jul 28, 2020
07:00AM EDT  Avanos Medical, Inc. To Webcast Conference Call Discussing Second Quarter 2020   PR Newswire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC